The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study

International Journal of Cancer

Volumn 138, Issue 4, 2016, Pages 939-948

  Mege, Diane ^a,b   Panicot Dubois, Laurence ^a   Ouaissi, Mehdi ^b   Robert, Stéphane ^a   Sielezneff, Igor ^a,b   Sastre, Bernard ^b   Dignat George, Françoise ^a,c   Dubois, Christophe ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

colorectal cancer; microparticle; microparticulosome; pancreatic cancer

Indexed keywords

LIPOCORTIN 5; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER SURGERY; CELLULAR PARAMETERS; CIRCULATING MICROPARTICLE CONCENTRATION; CIRCULATING MICROPARTICLE ORIGIN; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CHRONIC PANCREATITIS; COLITIS; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CELL-DERIVED MICROPARTICLES; COLITIS; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; PROSPECTIVE STUDIES;

EID: 84954386094     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29837     Document Type: Article

References (29)

1. Piccin A, Murphy WG, Smith OP., Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-71.
2. Zahra S, Anderson JAM, Stirling D, et al., Microparticles, malignancy and thrombosis. Br J Haematol 2011; 152: 688-700.
3. Barteneva NS, Fasler-Kan E, Bernimoulin M, et al., Circulating microparticles: square the circle. BMC Cell Biol 2013; 14: 23.
4. Lacroix R, Dignat-George F., Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb Res 2012; 129 (Suppl 2): S27-S29.
5. Rak J., Microparticles in cancer. Semin Thromb Hemost 2010; 36: 888-906.
6. D'Souza-Schorey C, Clancy JW., Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012; 26: 1287-99.
7. Van Doormaal FF, Kleinjan A, Di Nisio M, et al., Cell-derived microvesicles and cancer. Neth J Med 2009; 67: 266-73.
8. Chew HK, Wun T, Harvey D, et al., Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006; 166: 458-64.
9. Khorana AA, Francis CW, Menzies KE, et al., Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 2008; 6: 1983-5.
10. Manly DA, Wang J, Glover SL, et al., Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 2010; 125: 511-12.
11. Zwicker JI, Liebman HA, Neuberg D, et al., Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 2009; 15: 6830-40.
12. Tesselaar MET, Romijn FPHTM, Van Der Linden IK, et al., Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5: 520-7.
13. Thaler J, Ay C, Mackman N, et al., Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost 2012; 10: 1363-70.
14. Hron G, Kollars M, Weber H, et al., Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007; 97: 119-23.
15. Van den Hengel LG, Van Steijn-van Tol AQMJ, Bertina RM, et al., Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients. Thromb Res 2013; 131: 187-9.
16. Auwerda JJA, Yuana Y, Osanto S, et al., Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 2011; 105: 14-20.
17. Baran J, Baj-Krzyworzeka M, Weglarczyk K, et al., Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010; 59: 841-50.
18. Fleitas T, Martínez-Sales V, Vila V, et al., Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS One 2012; 7: e47365.
19. Graves LE, Ariztia EV, Navari JR, et al., Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 2004; 64: 7045-9.
20. Liebhardt S, Ditsch N, Nieuwland R, et al., CEA-, Her2/neu-, BCRP- and Hsp27-positive microparticles in breast cancer patients. Anticancer Res 2010; 30: 1707-12.
21. Kim HK, Song KS, Park YS, et al., Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003; 39: 184-91.
22. Lacroix R, Judicone C, Poncelet P, et al., Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012; 10: 437-46.
23. Robert S, Lacroix R, Poncelet P, et al., High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles-brief report. Arterioscler Thromb Vasc Biol 2012; 32: 1054-8.
24. Lacroix R, Robert S, Poncelet P, et al., Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 2571-4.
25. Caby M-P, Lankar D, Vincendeau-Scherrer C, et al., Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005; 17: 879-87.
26. Ratajczak J, Wysoczynski M, Hayek F, et al., Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-95.
27. Thomas GM, Panicot-Dubois L, Lacroix R, et al., Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 2009; 206: 1913-27.
28. Lowe KL, Navarro-Nunez L, Watson SP., Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb Res 2012; 129: S30-S37.
29. Wicki A, Christofori G., The potential role of podoplanin in tumour invasion. Br J Cancer 2007; 96: 1-5.